Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance
Patients With Pulmonary Hypertension or Interstitial Lung Disease Travelling to Altitude - Effect of Nocturnal Oxygen Therapy on Exercise Performance
Sponsor: University of Zurich
A PHASE4 clinical study on Interstitial Lung Disease and Precapillary Pulmonary Hypertension, this trial is completed. The trial is conducted by University of Zurich and has accumulated 8 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Mar 2020 [monthly]
Active Not Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .